» Articles » PMID: 36683712

Vibrational Spectroscopy - Are We Close to Finding a Solution for Early Pancreatic Cancer Diagnosis?

Overview
Specialty Gastroenterology
Date 2023 Jan 23
PMID 36683712
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer (PC) is an aggressive and lethal neoplasm, ranking seventh in the world for cancer deaths, with an overall 5-year survival rate of below 10%. The knowledge about PC pathogenesis is rapidly expanding. New aspects of tumor biology, including its molecular and morphological heterogeneity, have been reported to explain the complicated "cross-talk" that occurs between the cancer cells and the tumor stroma or the nature of pancreatic ductal adenocarcinoma-associated neural remodeling. Nevertheless, currently, there are no specific and sensitive diagnosis options for PC. Vibrational spectroscopy (VS) shows a promising role in the development of early diagnosis technology. In this review, we summarize recent reports about improvements in spectroscopic methodologies, briefly explain and highlight the drawbacks of each of them, and discuss available solutions. The important aspects of spectroscopic data evaluation with multivariate analysis and a convolutional neural network methodology are depicted. We conclude by presenting a study design for systemic verification of the VS-based methods in the diagnosis of PC.

Citing Articles

Combined analytical approach empowers precise spectroscopic interpretation of subcellular components of pancreatic cancer cells.

Szymonski K, Skirlinska-Nosek K, Lipiec E, Sofinska K, Czaja M, Wilkosz N Anal Bioanal Chem. 2023; 415(29-30):7281-7295.

PMID: 37906289 PMC: 10684650. DOI: 10.1007/s00216-023-04997-w.


Variabilities in global DNA methylation and β-sheet richness establish spectroscopic landscapes among subtypes of pancreatic cancer.

Szymonski K, Lipiec E, Sofinska K, Skirlinska-Nosek K, Czaja M, Seweryn S Eur J Nucl Med Mol Imaging. 2023; 50(6):1792-1810.

PMID: 36757432 PMC: 10119063. DOI: 10.1007/s00259-023-06121-7.

References
1.
Gui J, Yan W, Liu X . CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis. Clin Exp Med. 2013; 14(2):225-33. DOI: 10.1007/s10238-013-0234-9. View

2.
Veronezi G, Felisbino M, Gatti M, Mello M, de Campos Vidal B . DNA Methylation Changes in Valproic Acid-Treated HeLa Cells as Assessed by Image Analysis, Immunofluorescence and Vibrational Microspectroscopy. PLoS One. 2017; 12(1):e0170740. PMC: 5256918. DOI: 10.1371/journal.pone.0170740. View

3.
de Campos Vidal B, Ghiraldini F, Mello M . Changes in liver cell DNA methylation status in diabetic mice affect its FT-IR characteristics. PLoS One. 2014; 9(7):e102295. PMC: 4096918. DOI: 10.1371/journal.pone.0102295. View

4.
Shi Y, Gao W, Lytle N, Huang P, Yuan X, Dann A . Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. 2019; 569(7754):131-135. PMC: 6565370. DOI: 10.1038/s41586-019-1130-6. View

5.
Ali S, Bonnier F, Tfayli A, Lambkin H, Flynn K, McDonagh V . Raman spectroscopic analysis of human skin tissue sections ex-vivo: evaluation of the effects of tissue processing and dewaxing. J Biomed Opt. 2012; 18(6):061202. DOI: 10.1117/1.JBO.18.6.061202. View